Oxybutynin 3% gel for the treatment of primary focal hyperhidrosis in adolescents and young adults

ConclusionOxybutynin 3% gel reduced hyperhidrosis severity and improved health‐related quality of life in this small pilot study. Safety and efficacy should be further evaluated in a large, prospective, placebo‐controlled study.

Source: Pediatric Dermatology - January 15, 2018 Category: Dermatology Authors: Nicholas V. Nguyen, Jane Gralla, James Abbott, Anna L. Bruckner Tags: ORIGINAL ARTICLE Source Type: research